![Keiji Nishida](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Keiji Nishida
Direktor/Vorstandsmitglied bei Bio Palette Co., Ltd.
Ursprung des Netzwerks ersten Grades von Keiji Nishida
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Bio Palette Co., Ltd.
![]() Bio Palette Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Bio Palette Co., Ltd. provides genetic modification services for microbes, therapeutics and agriculture industries. The company was founded by Shoko Murase and Akihiko Kondo on February 21, 2017 and is headquartered in Kobe, Japan.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Keiji Nishida
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Connecticut Innovations, Inc.
![]() Connecticut Innovations, Inc. Investment ManagersFinance Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut. | Investment Managers | Corporate Officer/Principal | |
CardioKine, Inc.
![]() CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Pharmaceuticals: Major | Director/Board Member | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
FoldRx Pharmaceuticals LLC
![]() FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
NextWave Pharmaceuticals, Inc.
![]() NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Iora Health LLC
![]() Iora Health LLC Medical/Nursing ServicesHealth Services Iora Health, Inc. engages in the provision of healthcare services. It operates a primary care practice for college employees and their adult dependents; a clinic that serves hotel and restaurant workers; a family practice for individuals who receive health insurance; and a primary care practice to provide services to carpenters and their family members. The company was founded by Rushika Fernandopulle and Christopher J. McKown in 2010 and is headquartered in Cambridge, MA. | Medical/Nursing Services | Director/Board Member | |
Compass Therapeutics LLC
![]() Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Arthur D. Little, Inc.
![]() Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree | |
University of Hitotsubashi | College/University | Undergraduate Degree | |
Kyoto University | College/University | Undergraduate Degree | |
RespiVert Ltd.
![]() RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Medical Distributors | Director/Board Member | |
Biomaster, Inc.
![]() Biomaster, Inc. Medical/Nursing ServicesHealth Services Biomaster, Inc. engages in the operation and management of a hospitals. It specializes in cell-assisted lipotransfer tissue augmentation procedures. It offers various medical services using cell-assisted lipotransfer tissue augmentation procedures, such as breast augmentation, breast reconstruction and restoration, wrinkle removal, and buttock lift. It also involves in the integration of regenerative medicine and plastic surgery, as well as offers various services, including cell source development, tissue/cell banking, development and sale of devices, development of cell preservation, cultivation, and transplantation technologies. The company was founded on December 25, 2002 and is headquartered in Yokohama, Japan. | Medical/Nursing Services | Founder | |
Optegra Eyecare Ltd. | Director/Board Member | ||
Pharmos, Inc. | Director/Board Member | ||
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director/Board Member | |
Mikatus Inc.
![]() Mikatus Inc. Information Technology ServicesTechnology Services Mikatus Inc. provides accounting system solutions. It develops and sale of cloud-based accounting systems and tax application software for professional accounting firms. It also provides accounting equipment sales, systems maintenance, and portal site development. The company was founded by Toshinao Morizaki in June 2009 and is headquartered in Tokyo, Japan. | Information Technology Services | Director/Board Member | |
INNOVENT BIOLOGICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Eight Roads Ventures Japan
![]() Eight Roads Ventures Japan Investment ManagersFinance Eight Roads Ventures Japan is a Private Equity/Venture Capital firm, a subsidiary of FIL Ltd. founded in 2008. Eight Roads Ventures Japan is headquartered in Tokyo. | Investment Managers | Private Equity Investor | |
The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree | |
Harvard Business School | College/University | Masters Business Admin | |
Pulmocide Ltd.
![]() Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Yale School of Management | College/University | Masters Business Admin | |
Yale School of Medicine | College/University | Doctorate Degree | |
Impresa Management LLC
![]() Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Investment Managers | President | |
DENALI THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
Sensyn Robotics, Inc.
![]() Sensyn Robotics, Inc. Aerospace & DefenseElectronic Technology Sensyn Robotics, Inc. provides robotics services for visual communication through drones. The drones can be used for disaster measures and maintenance and inspection for social infrastructure and large scale facilities or plants. The company was founded in October 2015 and is headquartered in Tokyo, Japan. | Aerospace & Defense | Director/Board Member | |
BEAM THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
Azit, Inc.
![]() Azit, Inc. Packaged SoftwareTechnology Services Azit, Inc. develops software applications for car sharing transportation. The Japanese company was founded in 2013 by Shinichiro Sudo and Hiromasa Yoshikane. Hiromasa Yoshikane has been the CEO since 2013. | Packaged Software | Director/Board Member | |
SANA BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
F-Prime UK Ltd.
![]() F-Prime UK Ltd. Miscellaneous Commercial ServicesCommercial Services F-Prime UK Ltd. was founded in 2007 and provides strategy development, market research, investment advisory, and administration support services. The private company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Atalanta Therapeutics, Inc.
![]() Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Miscellaneous Commercial Services | Director/Board Member | |
PRIME MEDICINE, INC. | Biotechnology | Director/Board Member | |
Synplogen Co., Ltd.
![]() Synplogen Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Synplogen Co., Ltd. is a synthetic biology startup that provides DNA synthesis and DNA library construction services using their proprietary DNA synthesis technologies OGAB™ and Combinatorial-OGAB. The company was founded in 2017 by Akihiko Kondo and Kenji Tsuge and is based in Kobe, Japan. The Japanese company also offers design, development, and analysis services for gene therapy products such as viral vectors through their Gene Therapy Biofoundry™ service. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Geneception, Inc.
![]() Geneception, Inc. BiotechnologyHealth Technology Geneception, Inc. provides healthcare services. The company is headquartered in Cambridge, MA. | Biotechnology | President | |
Ensoma, Inc.
![]() Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Miscellaneous Commercial Services | Director/Board Member | |
SDP Japan KK
![]() SDP Japan KK Medical DistributorsDistribution Services SDP Japan KK is a company that was founded in 2014 and is based in Tokyo, Japan. The Japanese company produces supercutors to concentrate on medical care and has a joint purchase business of medical materials. SDP is a platformer that contributes to the medical industry by producing super doctors in a unique business model that has never been seen before. The company aims to create a medical environment where doctors can be engaged with pride and provide surgery to patients early to support the healthy and happy life of patients through medical care. The eternal director, who has launched about 30 companies in a wide variety of industries, is aiming in the medical industry. | Medical Distributors | Director/Board Member | |
Leyden Laboratories B.V.
![]() Leyden Laboratories B.V. Miscellaneous Commercial ServicesCommercial Services Leyden Laboratories B.V. is a biotechnology company based in Amsterdam, Netherlands. Leyden Labs aims to protect humanity from known and future viruses by targeting commonalities of viral families. The Dutch company has developed a portfolio of accessible intranasal product candidates that may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The company's energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses. Leyden Labs is backed with $200m by blue-chip investors Casdin Capital, GV (formerly Google Ventures), F-Prime Capital, Byers Capital/Brook Byers, SoftBank Investment Advisers, Invus, and Bluebird Ventures. The company was founded in June 2020 by Koenraad Wiedhaup, Jaap Goudsmit, Domenico Valerio, and Ronald H. P. Brus, with Koenraad Wiedhaup serving as the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Proof Diagnostics, Inc.
![]() Proof Diagnostics, Inc. Medical SpecialtiesHealth Technology Proof Diagnostics, Inc. is a company that specializes in providing affordable and accessible COVID-19 molecular testing using CRISPR technology. The company is based in Cambridge, MA. Led by world-renowned molecular biologist Dr. Feng Zhang, the company aims to help communities take control of their health. Proof Diagnostics was founded in 2020 by Feng Zhang, Sid Shenai, Jonathan Gootenberg, Omar Abudayyeh. Sid Shenai has been the CEO since 2020. | Medical Specialties | Director/Board Member | |
Aerium Therapeutics, Inc.
![]() Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Director/Board Member | |
Paradigm Health, Inc.
![]() Paradigm Health, Inc. Packaged SoftwareTechnology Services Paradigm Health, Inc. develops a platform for clinical research. The company is based in New York, NY and has subsidiaries in the United States. The company was founded by Milind Kamkolkar. Kent Thoelke has been the CEO of the company since 2023. | Packaged Software | Director/Board Member | |
METAPS INC. | Information Technology Services | Director/Board Member | |
Semma Therapeutics, Inc.
![]() Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member |
Statistik
International
Vereinigte Staaten | 36 |
Japan | 11 |
Vereinigtes Königreich | 4 |
China | 2 |
Niederlande | 2 |
Sektoral
Health Technology | 21 |
Commercial Services | 9 |
Consumer Services | 8 |
Technology Services | 6 |
Finance | 4 |
Operativ
Director/Board Member | 41 |
President | 5 |
Founder | 5 |
Undergraduate Degree | 4 |
Corporate Officer/Principal | 3 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Stephen Knight | 39 |
David Milstein | 9 |
Akihiko Kondo | 3 |
Kazuhiko Yamamoto | 3 |
Shoko Murase | 2 |
- Börse
- Insiders
- Keiji Nishida
- Unternehmensverbindungen